Chronic News and Research

RSS

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) of the Eon Mini™ spinal cord stimulation (SCS) system. The world's smallest, longest-lasting rechargeable neurostimulator, the Eon Mini device is the first rechargeable spinal cord stimulator to be approved for use in Japan.

30 Sep 2010

Avila commences AVL-292 Phase 1 clinical study for B cell cancers and autoimmune diseases

Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.

30 Sep 2010

Aethlon Medical engages Fabiani & Company to assist in establishment of federal partnerships

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has engaged Fabiani & Company to assist in the establishment of federal partnerships that advance biodefense, cancer, and chronic infectious disease applications of the Aethlon Hemopurifier®.

30 Sep 2010

Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Repligen Corporation reported today that it has completed enrollment of patients in its Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.

30 Sep 2010

Children with eczema at greater risk of developing asthma and food allergies

Children with eczema, a chronic skin condition that often begins in childhood, have a greater risk of developing asthma and food allergies. The number of children with eczema is rising, but the reasons for this are unclear. A new study soon to be published in The Journal of Pediatrics examines the relationship between pet ownership and eczema. Researchers found that dog ownership among children with dog allergies may reduce the risk of developing eczema by age 4 years; cat ownership, however, may increase the risk among children with cat allergies.

30 Sep 2010

Cardium expands wound healing and tissue regeneration portfolio

Cardium Therapeutics announced that it has gained exclusive access to commercial development rights for certain novel supramacromolecular polymer complexes enabling regulatable and localized topical delivery of nitric oxide for prolonged periods of one to three weeks, to broaden and expand the Company's wound healing and tissue regeneration portfolio.

30 Sep 2010

Tengion presents Neo-Kidney Augment development program at ISCT Symposium

Tengion, Inc. presented new research data yesterday in a podium presentation at the 2nd Annual Symposium on Stem Cell Translation of the International Society for Cellular Therapy (ISCT) in San Francisco. The presentation highlighted new results from Tengion's Neo-Kidney Augment development program demonstrating success with an autologous cellular therapy approach to kidney regeneration in a rodent model of obesity, diabetes and hypertension.

30 Sep 2010

New online CDSMP program launched to battle against chronic illnesses

Taking the battle against the national epidemic of chronic illnesses to the Internet, the National Council on Aging (NCOA) is making Better Choices, Better Health, the online version of the internationally recognized Chronic Disease Self Management Program (CDSMP), available free for people in California and six other states Hawaii, Iowa, Maine, Massachusetts, New Jersey, and Oregon.

30 Sep 2010

First preventative approach to improve outcomes in traumatized children

After experiencing a potentially traumatic event - a car accident, a physical or sexual assault, a sports injury, witnessing violence - as many as 1 in 5 children will develop Posttraumatic Stress Disorder (PTSD).

30 Sep 2010

Tobira completes $31 million Series B financing

Tobira Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative antiviral compounds to treat HIV disease, today announced the completion of a $31 million Series B financing. New investor Novo A/S is leading the round, joined by original investors, Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners and Canaan Partners.

30 Sep 2010

Consumption of diet high in trans fats by mothers doubles risk of high body fat levels in infants

A new University of Georgia study suggests that mothers who consume a diet high in trans fats double the likelihood that their infants will have high levels of body fat.

30 Sep 2010

Researchers explain why obesity is resistant to treatment

New research provides evidence of the vicious cycle created when an obese individual overeats to compensate for reduced pleasure from food.Obese individuals have fewer pleasure receptors and overeat to compensate, according to a study by University of Texas at Austin senior research fellow and Oregon Research Institute senior scientist Eric Stice and his colleagues published this week in The Journal of Neuroscience.

30 Sep 2010

Researchers develop genetic screening method to identify drug-resistant HCV strains

In recent human trials for a promising new class of drug designed to target the hepatitis C virus (HCV) without shutting down the immune system, some of the HCV strains being treated exhibited signs of drug resistance.

30 Sep 2010

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company announced today that it has published results in the American Journal of Respiratory and Critical Care Medicine from its double-blind, placebo-controlled, randomized Phase IIa study of ALN-RSV01 in lung transplant patients naturally infected with respiratory syncytial virus (RSV).

30 Sep 2010

Swine flu no longer a threat to Americans: Report

According to the latest research most Americans are immune to the swine flu virus. Results of the study by the National Institute of Allergy and Infectious Diseases, published in the journal mBio show that around 59 percent of the 310 million U.S. population has developed immunity to H1N1 either from exposure to similar viruses, vaccination, or natural H1N1 infection.

29 Sep 2010

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

Quick-Med Technologies, Inc.a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today its NIMBUS and Stay Fresh antimicrobial technologies will be highlighted at the 2010 Clinical Symposium on Advances in Skin and Wound Care, to be held in Orlando, Florida from September 30 – October 3, 2010.

29 Sep 2010

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes.

29 Sep 2010

New computer program to help young adults manage mental illness

While many young adults will share the details of their daily lives with dozens - sometimes hundreds - of friends on Facebook, communicating with their health care providers about mental illness is another story.

29 Sep 2010

Inefficiencies in treatment of chronic pain increases healthcare costs and prolongs patient suffering

A new report launched today in the European Parliament shows inefficiencies in the treatment of chronic pain result in increasing healthcare costs and prolonged patient suffering.

29 Sep 2010

HHS Secretary announces $320M ACA grants to strengthen health care workforce

HHS Secretary Kathleen Sebelius has announced $320 million in grants under the Affordable Care Act (ACA) to strengthen the health care workforce. Of those grants, $253 million will go to improve and expand the primary care workforce under the Prevention and Public Health Fund of the Affordable Care Act.

29 Sep 2010

Chronic News and Research

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

Avila commences AVL-292 Phase 1 clinical study for B cell cancers and autoimmune diseases

Aethlon Medical engages Fabiani & Company to assist in establishment of federal partnerships

Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Children with eczema at greater risk of developing asthma and food allergies

Cardium expands wound healing and tissue regeneration portfolio

Tengion presents Neo-Kidney Augment development program at ISCT Symposium

New online CDSMP program launched to battle against chronic illnesses

First preventative approach to improve outcomes in traumatized children

Tobira completes $31 million Series B financing

Consumption of diet high in trans fats by mothers doubles risk of high body fat levels in infants

Researchers explain why obesity is resistant to treatment

Researchers develop genetic screening method to identify drug-resistant HCV strains

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Swine flu no longer a threat to Americans: Report

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

New computer program to help young adults manage mental illness

Inefficiencies in treatment of chronic pain increases healthcare costs and prolongs patient suffering

HHS Secretary announces $320M ACA grants to strengthen health care workforce

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News